NCT03259542View on ClinicalTrials.gov

Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 9, 2017

Primary Completion Date

December 11, 2017

Study Completion Date

December 11, 2017

Conditions
Drug Interaction PotentiationHealthy
Interventions
DRUG

Mifepristone 300 MG

mifepristone 300 MG (4 tablets) orally for a total of 1200 mg a day for 14 days; then mifepristone 300 mg (3 tablets) orally for a total of 900 mg a day for 28 days

DRUG

Itraconazole 100 MG

itraconazole 100 MG (2 capsules) orally for a total of 200 MG for the last 14 days of mifepristone dosing

Trial Locations (1)

33126

SeaView Research, Miami

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY